# Exercise and glucagon-like peptide 1 receptor agonists in cardiovascular disease beyond weight loss

> **Open Intelligence Dossier** · First detected: 2026-06-26 07:07 UTC · Category: Health

## Executive Summary
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"Exercise and glucagon-like peptide 1 receptor agonists in cardiovascular disease beyond weight loss" is generating significant coverage in the Health category, with 1 articles from 1 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Nature. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Nature | Exercise and glucagon-like peptide 1 receptor agonists in cardiovascular disease beyond weight loss | [Source Link](https://news.google.com/rss/articles/CBMiX0FVX3lxTE5fX2JSMFdVa3cyRGNodHNiWVYtdlZWRDlRb0Z3dHJnbmMxU0VPUDdsc1NTQkdZc3NDTnNqQktGNkROa2lRdFhJOHRZRGVJZlFuaUhrbmNic21sMTdMRTVR?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-06-26/exercise-and-glucagon-like-peptide-1-receptor-agonists-in-cardiovascular*